Skip to main content

Epidemiology of Leprosy

  • Chapter
Mycobacteria

Part of the book series: Chapman & Hall Medical Microbiology Series ((CHMMS))

Abstract

Leprosy, from an epidemiological point of view, is a disease with several interesting features. Among these, one should mention its high infectivity and low pathogenicity, its prolonged incubation period, and its high tendency for spontaneous healing, in addition to its wide range of manifestations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. World Health Organization (1988) Report of the Expert Committee on Leprosy-6th report, p. 14. Geneva: World Health Organization.

    Google Scholar 

  2. Bechelli LM, Martinez Dominguez V (1966) The leprosy problem in the world. Bull. WHO 34:811–826.

    PubMed  CAS  Google Scholar 

  3. Anonymous (1994) Progress towards eliminating leprosy as a public health problem. WHO Wkly Epidemiol Rec 20:145–151; 21:153–157.

    Google Scholar 

  4. Noordeen SK (1994) Epidemiology of leprosy. In: Hastings RC, ed. Leprosy, pp. 29– 45. London: Churchill Livingstone.

    Google Scholar 

  5. Doull JA, Guinto RS, Rodriguez JN, Bancroft H (1942) The incidence of leprosy in Cordova and Talisay, Cebu, P.I. Int J Leprosy 10:107–131.

    Google Scholar 

  6. Irgens LM (1980) Leprosy in Norway—an epidemiological study based on a national patient registry. Leprosy Rev 51(Suppl 1):1–130.

    Google Scholar 

  7. Wade HW, Ledowsky V (1952) The leprosy epidemic at Nauru: a review with data on the status since 1937. Int J Leprosy 20:1–29.

    PubMed  CAS  Google Scholar 

  8. Lara CB, Nolasco JO (1956) Self-healing or abortive and residual forms of childhood leprosy and their probable significance. Int J Leprosy 24:245–263.

    PubMed  CAS  Google Scholar 

  9. Noordeen SK (1975) Evolution of tuberculoid leprosy in a community. Leprosy India 47:85–93.

    Google Scholar 

  10. Guinto RS, Doull JA, de Guia L, Rodriguez JN (1954) Mortality of persons with leprosy prior to sulfone therapy, Cordova and Talisay, Cebu, Philippines. Int J Leprosy 22:273–284.

    PubMed  CAS  Google Scholar 

  11. Noordeen SK (1972) Mortality in leprosy. Indian J Med Res 60:439–445.

    PubMed  CAS  Google Scholar 

  12. Figueredo N, Desai SD (1949) Positive bacillary findings in the skin of contacts of leprosy patients. Indian J Med Sci 3:253–265.

    Google Scholar 

  13. Chatterjee BR (1976) Carrier state in leprosy. Leprosy India 48:643–644.

    CAS  Google Scholar 

  14. Chacko CJG, Mohan M, Jesudasan K, Job CK, Fritschi EP(1979) Primary leprosy involvement of nasal mucosa in apparently healthy household contacts of leprosy patients. Abstracts of the XI Biennial Conference of the Indian Association of Leprologists.

    Google Scholar 

  15. Chatterjee BR, Tayler CE, Thomas J, Naidu GN (1976) Acid fast bacillary positivity in asymptomatic individuals in leprosy endemic villages around Jhalda in West Bengal. Leprosy India 48:119–131.

    CAS  Google Scholar 

  16. Schaffer (1898) Uber de Verbreitung der Lepra bacillen von den oberen Luftwegen aus (The spread of leprosy bacilli from the upper parts of the respiratory tract). Arch Dermatol Syphil (Berlin) 44:159–174.

    Google Scholar 

  17. Shepard CC, Walker LL, Van Landingham RM, Ye SZ (1982) Sensitization or tolerance to Mycobacterium leprae antigen by route of infection. Infect Immun 38:673–680.

    PubMed  CAS  Google Scholar 

  18. Rees RJW, McDougall AC (1977) Airborne infection with Mycobacterium leprae in mice. J Med Microbiol 10:63–68.

    Article  PubMed  CAS  Google Scholar 

  19. Godal T, Negassi K (1973) Subclinical infection in leprosy. Br Med J 3:557–559.

    Article  PubMed  CAS  Google Scholar 

  20. Abe M, Minagawa F, Yoshino Y, Ozawa T, Saikawa A, Saito T (1980) Flourescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. Int J Leprosy 48:109–119.

    CAS  Google Scholar 

  21. Anonymous (1986) Serological tests for leprosy. Lancet 1:533–535.

    Google Scholar 

  22. Hunter SW, Brennen PI (1981) A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol 147:728– 735.

    PubMed  CAS  Google Scholar 

  23. Zuniga M, et al. (1982) Immunoprophylaxis trial in Venezuela. Preliminary results. Paper presented at the Conference and Workshop on Pathogenesis and Immunotherapy of Leprosy, National Institute of Dermatology (Pan American Center for Research and Training in Leprosy and Tropical Diseases, CEPIALET).

    Google Scholar 

  24. Noordeen SK (1978) Infectivity of leprosy. In: Chatterjee BR, ed. A Window on Leprosy, pp. 59–63. New Delhi: Ghandi Memorial Leprosy Foundation.

    Google Scholar 

  25. de Vries RRP, Van Eden W, Van Rood JJ (1981) HLA-linked control of the course of M. leprae infections. Leprosy Rev 52:109–119.

    PubMed  Google Scholar 

  26. Van Eden W (1983) HLA and leprosy—a model for the study of genetic control of immune response in man. Thesis Drukkerij JH, Pasmans BV, Gravenha GE, (Netherlands).

    Google Scholar 

  27. Shepard CC, Walker LL, Van Landingham RM, Ye SZ (1982) Sensitization or tolerance to Mycobacterium leprae antigen by route of infection. Infect Immun 38:673–680.

    PubMed  CAS  Google Scholar 

  28. Sundaresan T (1982) BCG vaccination of children against leprosy. Twelve years’ findings of the controled WHO trial in Burma. Paper presented at the Sixth IMMLEP Scientific Working Group Meeting.

    Google Scholar 

  29. Scott GC, Russell DA, Wigley SC (1982) The Karimuri trial of BCG as a leprosy prophylactic. Paper presented at the Sixth IMMLEP Scientific Working Group Meeting.

    Google Scholar 

  30. Stanley SJ, Howland C, Stone MM, Sutherland I (1981) BCG vaccination of children against leprosy in Uganda: final results. J Hyg (Camb.) 87:233–248.

    Article  CAS  Google Scholar 

  31. Tripathy SP (1983) ICMR Leprosy Prevention Trial. Paper presented at the Joint Indian and IMMLEP Scientific Meeting on Immuno-epidemiology of Leprosy.

    Google Scholar 

  32. Rook GAW, Bahr GM, Stanford JL (1981) The effect of two distinct forms of cellmediated response to mycobacteria on the protective efficacy of BCG. Tubercle 62:63— 68.

    Article  PubMed  CAS  Google Scholar 

  33. Meeran K (1989) Prevalence of HIV infection among patients with leprosy and tuberculosis in rural Zambia. Br Med J 298:364–365.

    Article  CAS  Google Scholar 

  34. Lucas S (1993) Human immunodeficiency virus and leprosy (editorial). Leprosy Rev 64:97–103.

    PubMed  CAS  Google Scholar 

  35. Lechat MF, Mission CB, Bouckaert A, Vellut C (1977) An epidemiometric model of leprosy: a computer simulation of various control methods with increasing coverage. Int J Leprosy 45:1–8.

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Noordeen, S.K. (1998). Epidemiology of Leprosy. In: Gangadharam, P.R.J., Jenkins, P.A. (eds) Mycobacteria. Chapman & Hall Medical Microbiology Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7511-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-7511-5_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-7513-9

  • Online ISBN: 978-1-4615-7511-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics